SequelSEC

UTAH MEDICAL PRODUCTS INC UTMD

Surgical & Medical Instruments & Apparatus · CIK 0000706698 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$36.11M
Fiscal year ended 2026-06-30
Operating income
$10.27M
Fiscal year ended 2026-06-30
Free cash flow
$11.45M
Fiscal year ended 2026-06-30

Valuation, from the filing

Public float$168.20MMarket value of stock held by non-affiliates, as stated on the cover page for 2025-06-30
Float per share$52.81Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself.
Float / revenue4.4×A lower bound on the multiple, because affiliate holdings are excluded.
Float / equity1.4×A lower bound on the multiple, because affiliate holdings are excluded.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-06-30, not today, and each multiple below it uses the figures for the fiscal year ending 2025-12-31 — the year that filing covered.

How this compares in its industry

Percentile among the Surgical & Medical Instruments & Apparatus filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.

MeasureReportedPercentile
FCF margin37.2%100th
Current ratio37.62x99th
Long-term debt / equity0.00x2th
Operating margin29.6%97th
R&D / revenue1.7%8th
SBC / revenue1.0%9th
Revenue YoY growth-5.8%17th
CapEx / revenue1.0%24th
Gross margin57.1%43th
Effective tax rate20.0%44th

UTAH MEDICAL PRODUCTS INC (UTMD) reported revenue of $36.11M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from UTAH MEDICAL PRODUCTS INC’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Surgical & Medical Instruments & Apparatus.

Income

UTAH MEDICAL PRODUCTS INC income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$36.11M
Cost of revenue$15.20M
Gross profit$20.91M
Operating income$10.27M
Net incomeUnavailable
Research & development$687.00K
Weighted-average diluted sharesUnavailable
Pretax income$12.88M
Income tax expense$2.40M
Diluted EPS$3.28
Selling, general & administrativeUnavailable
General & administrativeUnavailable
Selling & marketingUnavailable

Balance

UTAH MEDICAL PRODUCTS INC balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalents$87.53M
Total assets$124.57M
Current assets$100.64M
Total liabilities$2.54M
Current liabilities$2.07M
Total equity incl. NCI$122.03M
Temporary (mezzanine) equityUnavailable
Inventory$9.00M
Accounts receivable$3.56M
Goodwill$13.96M
Long-term debt$195.00K
Accounts payable$876.00K

Cash flow

UTAH MEDICAL PRODUCTS INC cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow$11.85M
Capital expenditures$400.00K
Investing cash flow-$400.00K
Financing cash flow-$5.79M
Net change in cash$5.35M
Stock-based compensation$397.00K
Common dividends paid$3.94M
Common share repurchases$1.85M
Depreciation & amortizationUnavailable

Derived

UTAH MEDICAL PRODUCTS INC derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flow$11.45M
Gross margin57.9%
Operating margin28.4%
FCF margin31.7%
SBC / revenue1.1%
Current ratio48.62x
Revenue YoY growth-7.0%
Net marginUnavailable
R&D / revenue1.9%
CapEx / revenue1.1%
Long-term debt / equity0.00x
Effective tax rate18.6%

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open UTMD in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-12View SEC filing
10-Q · Filed 2026-05-12View SEC filing
10-K · Filed 2026-03-27View SEC filing
10-Q · Filed 2025-11-14View SEC filing
10-Q · Filed 2025-08-12View SEC filing
10-Q · Filed 2025-05-15View SEC filing

Companies in the same industry

ADGM AEMD ALUR AMIX ANGO ANIK AORT APYX ARAY ATEC ATRC AURX

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.